Fosaprepitant Dimeglumine - NDC Database
7 records found
Page:
0143-9384 Sep 08, 2020
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
0143-9428 May 01, 2021
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
0781-3484 Feb 16, 2022
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc
55150-299 Jan 12, 2021
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Auromedics Pharma LLC
59651-523 Jan 12, 2021
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Aurobindo Pharma Limited
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Aurobindo Pharma Limited
67184-0540 Sep 08, 2020
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Qilu Pharmaceutical Co., Ltd.
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Qilu Pharmaceutical Co., Ltd.
82238-018 Jan 12, 2021
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Pharma Specialities Limited
Fosaprepitant Dimeglumine 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Eugia Pharma Specialities Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.